Feinberg experienced a year of outstanding growth, scientific achievement, and collaboration in 2022, from honors and awards to unprecedented research discoveries.
A team of Northwestern investigators led by Peter Penzes, PhD, has developed a new therapy that could treat Phelan-McDermid syndrome, a subtype of autism spectrum disorder.
Meet Kai Brady, a second-year MD student at Feinberg School of Medicine, and get a look at a typical day during this phase of her medical school career.
The Institute for Public Health and Medicine recently hosted its annual Population Health Forum, a celebration of the ten-year anniversary of the institute that brought together hundreds of public health researchers, trainees, and community partners.
Non-white racial and ethnic groups are underrepresented in OB-GYN clinical trials, according to a new Northwestern Medicine study.
A Northwestern Medicine study has discovered that elevated PALI1 in advanced prostate tumors mediates crosstalk between two primary epigenetic silencing mechanisms, suggesting that dual epigenetic inhibition may be an effective therapeutic strategy.
The Breakthroughs podcast released more than 20 episodes in 2022 on topics ranging from the role of dopamine in habit formation to music-based medical interventions.
Investigators have developed a novel personalized T-cell therapy approach that may identify specific targets unique to a patient’s cancer cells more effectively than current treatments, according to findings published in Nature.
Daniel Martin Watterson, PhD, the John G. Searle Professor of Molecular Biology and Biochemistry, has been named a 2022 fellow of the National Academy of Inventors.
Northwestern Medicine scientists have identified a new therapeutic target against tumor cells and developed a compound which slows tumor growth and bolsters immune response.